Deutsche Bank’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-174,702
| Closed | -$78.6K | – | 3675 |
|
|
2025
Q1 | $78.6K | Hold |
174,702
| – | – | ﹤0.01% | 3272 |
|
|
2024
Q4 | $87.4K | Buy |
174,702
+115,672
| +196% | +$84.9K | ﹤0.01% | 3321 |
|
|
2024
Q3 | $53.7K | Buy |
59,030
+1,419
| +2% | +$1.31K | ﹤0.01% | 3355 |
|
|
2024
Q2 | $57.6K | Sell |
57,611
-17,288
| -23% | -$19.1K | ﹤0.01% | 3294 |
|
|
2024
Q1 | $111K | Sell |
74,899
-1,496
| -2% | -$1.7K | ﹤0.01% | 3124 |
|
|
2023
Q4 | $83.3K | Sell |
76,395
-2,699
| -3% | -$2.96K | ﹤0.01% | 3302 |
|
|
2023
Q3 | $93.3K | Buy |
79,094
+68,147
| +623% | +$92.7K | ﹤0.01% | 3189 |
|
|
2023
Q2 | $15.4K | Buy |
+10,947
| New | +$15.1K | ﹤0.01% | 3605 |
|
|
2022
Q2 | – | Sell |
-68,085
| Closed | -$105K | – | 4239 |
|
|
2022
Q1 | $105K | Sell |
68,085
-8,076
| -11% | -$12.5K | ﹤0.01% | 3562 |
|
|
2021
Q4 | $187K | Buy |
76,161
+4,026
| +6% | +$9.42K | ﹤0.01% | 3420 |
|
|
2021
Q3 | $182K | Buy |
72,135
+143
| +0.2% | +$367 | ﹤0.01% | 3615 |
|
|
2021
Q2 | $205K | Buy |
+71,992
| New | +$186K | ﹤0.01% | 3773 |
|
|
2020
Q2 | – | Sell |
-33,680
| Closed | -$28K | – | 4356 |
|
|
2020
Q1 | $28K | Sell |
33,680
-2,188
| -6% | -$2.18K | ﹤0.01% | 3802 |
|
|
2019
Q4 | $31K | Buy |
35,868
+7,402
| +26% | +$6.17K | ﹤0.01% | 4148 |
|
|
2019
Q3 | $27K | Sell |
28,466
-5,283
| -16% | -$5.47K | ﹤0.01% | 4215 |
|
|
2019
Q2 | $37K | Sell |
33,749
-110,627
| -77% | -$127K | ﹤0.01% | 4629 |
|
|
2019
Q1 | $187K | Sell |
144,376
-232,474
| -62% | -$289K | ﹤0.01% | 4043 |
|
|
2018
Q4 | $343K | Buy |
376,850
+105,022
| +39% | +$161K | ﹤0.01% | 3570 |
|
|
2018
Q3 | $559K | Sell |
271,828
-14,838
| -5% | -$31.2K | ﹤0.01% | 3718 |
|
|
2018
Q2 | $517K | Sell |
286,666
-498,349
| -63% | -$1M | ﹤0.01% | 3828 |
|
|
2018
Q1 | $1.85M | Sell |
785,015
-385,329
| -33% | -$904K | ﹤0.01% | 2915 |
|
|
2017
Q4 | $2.2M | Buy |
1,170,344
+702,824
| +150% | +$1.53M | ﹤0.01% | 2656 |
|
|
2017
Q3 | $1.16M | Buy |
467,520
+253,886
| +119% | +$629K | ﹤0.01% | 2908 |
|
|
2017
Q2 | $587K | Buy |
213,634
+174,783
| +450% | +$488K | ﹤0.01% | 3361 |
|
|
2017
Q1 | $115K | Sell |
38,851
-8,228
| -17% | -$23.4K | ﹤0.01% | 3849 |
|
|
2016
Q4 | $147K | Buy |
47,079
+6,778
| +17% | +$20.8K | ﹤0.01% | 3855 |
|
|
2016
Q3 | $135K | Buy |
40,301
+3,640
| +10% | +$10.1K | ﹤0.01% | 3821 |
|
|
2016
Q2 | $82K | Sell |
36,661
-2,278
| -6% | -$5.59K | ﹤0.01% | 4193 |
|
|
2016
Q1 | $96K | Sell |
38,939
-9,982
| -20% | -$22.3K | ﹤0.01% | 4041 |
|
|
2015
Q4 | $161K | Sell |
48,921
-849
| -2% | -$2.54K | ﹤0.01% | 3835 |
|
|
2015
Q3 | $119K | Sell |
49,770
-55,270
| -53% | -$143K | ﹤0.01% | 4021 |
|
|
2015
Q2 | $307K | Buy |
105,040
+78,431
| +295% | +$304K | ﹤0.01% | 3662 |
|
|
2015
Q1 | $105K | Sell |
26,609
-2,513
| -9% | -$8.69K | ﹤0.01% | 4108 |
|
|
2014
Q4 | $86K | Buy |
29,122
+26,589
| +1,050% | +$71.9K | ﹤0.01% | 4817 |
|
|
2014
Q3 | $6K | Buy |
2,533
+360
| +17% | +$867 | ﹤0.01% | 5505 |
|
|
2014
Q2 | $5K | Sell |
2,173
-31,744
| -94% | -$71.7K | ﹤0.01% | 5627 |
|
|
2014
Q1 | $89K | Buy |
33,917
+15,803
| +87% | +$46.5K | ﹤0.01% | 4287 |
|
|
2013
Q4 | $52K | Sell |
18,114
-47,586
| -72% | -$144K | ﹤0.01% | 4334 |
|
|
2013
Q3 | $200K | Buy |
65,700
+28,474
| +76% | +$90.1K | ﹤0.01% | 4119 |
|
|
2013
Q2 | $118K | Buy |
+37,226
| New | +$119K | ﹤0.01% | 4134 |
|
Other funds holding LCTX
BC
DC
RA
